Screening a combinatorial peptide library to develop a human glandular kallikrein 2–activated prodrug as targeted therapy for prostate cancer
Janssen, Samuel, Jakobsen, Carsten M, Rosen, D Marc, Ricklis, Rebecca M, Reineke, Ulrich, Christensen, Soeren B, Lilja, Hans, Denmeade, Samuel R
Published in Molecular cancer therapeutics (01.11.2004)
Published in Molecular cancer therapeutics (01.11.2004)
Get full text
Journal Article
Prostate-Specific Antigen-Activated Thapsigargin Prodrug as Targeted Therapy for Prostate Cancer
Denmeade, Samuel R., Jakobsen, Carsten M., Janssen, Samuel, Khan, Saeed R., Garrett, Elizabeth S., Lilja, Hans, Christensen, S. Brogger, Isaacs, John T.
Published in JNCI : Journal of the National Cancer Institute (02.07.2003)
Published in JNCI : Journal of the National Cancer Institute (02.07.2003)
Get full text
Journal Article
Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug
Janssen, Samuel, Rosen, D. Marc, Ricklis, Rebecca M., Dionne, Craig A., Lilja, Hans, Christensen, Soeren B., Isaacs, John T., Denmeade, Samuel R.
Published in The Prostate (01.03.2006)
Published in The Prostate (01.03.2006)
Get full text
Journal Article
Composition and methods for treatment of congestive heart failure
LIU, QUE, SRIVASTAVA, VED, JODKA, CAROLYN, M, JANSSEN, SAMUEL, LEWIS, DIANA, Y, GHOSH, SOUMITRA, SHANKAR, LIN, QING, SOARES, CHRISTOPHER, J
Year of Publication 11.12.2013
Get full text
Year of Publication 11.12.2013
Patent